Finding a safe and effective intravenous iron treatment for restless legs syndrome

Sleep Medicine

Volumn 11, Issue 5, 2010, Pages 429-430

  Auerbach, Michael ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FERRIC GLUCONATE; FERRIC HYDROXIDE SUCROSE; FERRITIN; IRON; IRON DEXTRAN; PLACEBO; RECOMBINANT ERYTHROPOIETIN; ANTIANEMIC AGENT;

ANAPHYLAXIS; ANEMIA; CLINICAL TRIAL; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG MEGADOSE; DRUG RESPONSE; DRUG SAFETY; EDITORIAL; ERYTHROPOIESIS; FERRITIN BLOOD LEVEL; HEMODIALYSIS PATIENT; HUMAN; IRON DEFICIENCY; IRON THERAPY; LOW DRUG DOSE; MOLECULAR WEIGHT; PRIORITY JOURNAL; REPEATED DRUG DOSE; RESTLESS LEGS SYNDROME; SINGLE DRUG DOSE; UNSPECIFIED SIDE EFFECT; INTRAVENOUS DRUG ADMINISTRATION; NOTE;

HEMATINICS; HUMANS; INFUSIONS, INTRAVENOUS; IRON-DEXTRAN COMPLEX; RESTLESS LEGS SYNDROME;

EID: 77954680485     PISSN: 13899457     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sleep.2010.01.003     Document Type: Editorial

References (22)

1. Baird I.M., Padmore D.A. Intra-muscular iron therapy in iron deficiency anemia. Lancet 1954, 2:942.
2. Hamstra Rd., Block M.H., Schocket A.L. Intravenous iron dextran in clinical medicine. JAMA 1980, 243:1726-1731.
3. Eschbach J.W., Egrie J.C., Downing M.R., Browne J.K., Adamson J.W. Correction of anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial. N Engl J Med 1987, 316:73-78.
4. Fishbane S., Frei G.L., Maesaka J. Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementation. Am J Kidney Dis 1995, 26:41-46.
5. Auerbach M., Coyne D., Ballard H. Intravenous iron: from anathema to standard of care. Am J Hematol 2008, 83:580-588.
6. Rodgers G.M., Auerbach M., Cella D., et al. High-molecular weight iron dextran: a wolf in sheep's clothing?. J Am Soc Nephrol 2008, 19:833-834.
7. Case G. Maintaining iron balance with total-dose infusion of intravenous iron dextran. ANNA J 1998, 25:65-68.
8. Mamula P., Piccoli D.A., Peck S.N., et al. Total dose intravenous infusion of iron dextran for iron-deficiency anemia in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2002, 34:286-290.
9. Michael B., Coyne D.W., Fishbane S., et al. Sodium ferric gluconate complex in hemodialysis patients: adverse reactions compared to placebo and iron dextran. Kidney Int 2002, 61:1830-1839.
10. Coyne D.W., Adkinson N.F., Nissenson A.R., et al. Sodium ferric gluconate complex in hemodialysis patients. II. Adverse reactions in iron dextran-sensitive and dextran-tolerant patients. Kidney Int 2003, 63:217-224.
11. Chertow G.M., Mason P.D., Vaage-Nilsen O., et al. On the relative safety of parenteral iron formulations. Nephrol Dial Transplant 2004, 19:1571-1575.
12. Auerbach M., Ballard H. Intravenous iron in oncology. J Natl Compr Canc Netw 2008, 6:585-592.
13. Auerbach M., Rodgers G.M. Intravenous iron. N Engl J Med 2007, 357:93-94.
14. Wang J., O'Reilly B., Venkataraman R., et al. Efficacy of oral iron in patients with restless legs syndrome and a low-normal ferritin: a randomized double-blind, placebo-controlled study. Sleep Med 2009, 9:973-975.
15. Earley C.J., Horska A., Mohamed M.A., et al. A randomized, double-blind, placebo-controlled trial of intravenous iron sucrose in restless legs syndrome. Sleep Med 2009, 10:206-211.
16. Grote L., Leissner L., Hedner J., et al. A randomized, double-blind, placebo controlled, multi-center study of intravenous iron sucrose and placebo in the treatment of restless legs syndrome. Mov Disord 2009, 24:1445-1452.
17. Chandler G., Harchowal J., Macdougall I.C. Intravenous iron sucrose: establishing a safe dose. Am J Kidney Dis 2001, 38:988-991.
18. Earley C.J., Heckler D., Horska A., et al. The treatment of restless legs syndrome with intravenous iron dextran. Sleep Med 2004, 5:231-235.
19. Nordlander N.B. Therapy in restless legs. Acta Med Scand 1953, 145:453-457.
20. Parrow A., Werner I. The treatment of restless legs. Acta Med Scand 1996, 180:401-406.
21. Ondo W.G. Intravenous iron dextran for refractory restless legs syndrome. Sleep Med 2010, 11:494-496.
22. Auerbach M., Pappadakis J., Bahrain H., et al. Rapid (sixty minutes) infusion of one gram of low molecular weight iron dextran: safety and efficacy profile. Blood 2009, 114(Suppl.):1555. [Presented at annual meeting of Am Soc Heme, New Orleans, LA].